Oric Pharmaceuticals (ORIC) Accounts Payables (2019 - 2026)

Oric Pharmaceuticals' Accounts Payables history runs 8 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• Quarterly Accounts Payables fell 43.9% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 43.9% YoY) and the FY2025 annual result came in at $3.8 million, up 147.03% from the prior year.
• Accounts Payables was $2.9 million for Q1 2026 at Oric Pharmaceuticals, down from $3.8 million in the prior quarter.
• Across five years, Accounts Payables topped out at $5.2 million in Q1 2025 and bottomed at $888000.0 in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.9 million in 2026 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables jumped 265.63% — and 2026, when it tumbled 43.9%.
• Oric Pharmaceuticals' Accounts Payables stood at $1.3 million in 2022, then slipped by 28.48% to $944000.0 in 2023, then jumped by 63.98% to $1.5 million in 2024, then soared by 147.03% to $3.8 million in 2025, then retreated by 24.29% to $2.9 million in 2026.
• Business Quant data shows ORIC's Accounts Payables at $2.9 million in Q1 2026, $3.8 million in Q4 2025, and $2.9 million in Q3 2025.